Pre-Inspection Readiness
Master Compliance with our Mock Inspections for Your Seamless Pre-inspection Readiness
Master Compliance with our Mock Inspections for Your Seamless Pre-inspection Readiness
The pharmaceutical manufacturing industry requires rigorous audit and inspection readiness to ensure compliance with quality standards. These inspections are crucial for ensuring the quality and safety of pharmaceutical products. Therefore, pharmaceutical companies must approach these inspections with careful planning, attention to detail, and a proactive mind-set.
Zenovel acknowledges the demanding and time-consuming nature of preparing for audit and inspection. Our team of professionals offers comprehensive simulated inspection services to help prepare your facility for US-FDA, EMA, and MHRA inspection. We conducts audit or mock inspection, review your documentations and quality systems, validate your process, and provide valuable feedback on areas for improvement.
To effectively prepare, first acquaint yourself with the inspection procedure. The following phases are involved:
The FDA field inspector’s conducts inspection at facilities, reviewing records, interviewing personnel, and assessing compliance with regulations.
The FDA releases an inspection report outlining any observations or conclusions.
The FDA informs pharmaceutical company of an upcoming inspection, which can be given as little as five days or weeks in advance, even sometimes a surprised visit happens
Pharmaceutical company should conduct a comprehensive self-assessment, evaluate all SOP’s and regulatory documentation, and thoroughly examine processes to ensure easy accessibility of all relevant material.
To pass an FDA inspection, a proactive, risk-based strategy is necessary for effective quality system, process, and regulatory adherence, requiring crucial preparatory actions.
The implementation of internal mock inspections can identify readiness gaps, familiarize staff with the inspection procedure, and offer practical experience in handling inquiries. Our mock inspection readiness services offers simulate real inspection scenarios, reviewing processes, quality management system, documentation, and compliance levels. We identify gaps and provide targeted recommendations, ensuring your team is well-prepared for regulatory audits, reducing non-compliance risks, and enhancing inspection outcomes.
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
The international pharmaceutical landscape is inherently connected to the global economy and global trade, which is consisted with the quality and safety assurance , well-controlled quality and safety. Compliance with international pharmaceutical standards has changed from an optional step to a requirement. The Pharmaceutical Inspection Co-operation Scheme (PIC/S Certification) is
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.